Evidence map›Paper›PMID 31493208›Full record

ArticleInternational journal of clinical pharmacy2019

An evaluation of mental health clinical pharmacist independent prescribers within general practice in remote and rural Scotland.

Elizabeth Buist, Rebecca McLelland, Gordon F Rushworth, Derek Stewart, Kathrine Gibson-Smith, Andrew MacLure, Scott Cunningham, Katie MacLure

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elizabeth BuistPharmacy Department, New Craigs Hospital, Leachkin Road, Inverness, IV3 8NP, UK. elizabeth.buist@nhs.net.
Rebecca McLellandPharmacy Department, New Craigs Hospital, Leachkin Road, Inverness, IV3 8NP, UK.
Gordon F RushworthHighland Pharmacy Education and Research Centre, Centre for Health Science, Old Perth Road, Inverness, IV2 3JH, UK.
Derek StewartCollege of Pharmacy, Qatar University Health, Qatar University, PO Box 2713, Doha, Qatar.ORCID http://orcid.org/0000-0001-7360-8592
Kathrine Gibson-SmithSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, AB10 7GJ, UK.
Andrew MacLureSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, AB10 7GJ, UK.
Scott CunninghamSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, AB10 7GJ, UK.
Katie MacLureSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, AB10 7GJ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background A 12-month pilot was implemented in two general practices in remote and rural Scotland, with patients referred by general practitioners to specialist mental health pharmacist independent prescribers. Objective The objective was to evaluate the pilot service from the perspectives of the patients and the care team. Methods The pharmacists routinely recorded patient-specific data of all clinical issues and their actions at the time of each consultation. Further datasets comprised baseline and follow-up Patient Health Questionnaire (PHQ-9) and/or Generalised Anxiety Disorder (GAD-7) rating scales, a patient survey and interviews with members of the care team. Results Of the 75 patients, two-thirds (n = 47, 62.7%) were referred with a diagnosis of mixed depression and anxiety. There were 324 consultations (median 3, IQR 2-5, range 1-14) and 181 prescribing actions. At pilot completion, 34 patients (45.3%) had PHQ-9 and/or GAD-7 scores reduced by 50%. Patient questionnaires and staff interviews generated positive responses. Conclusion This pilot has provided evidence that specialist mental health pharmacist independent prescribers delivered quality care to patients with diagnoses of moderate to severe depression and/or anxiety. Whilst accepting study limitations, there is potential to translate the pilot model of care to sustained services throughout general practice.

Indexed as

Drug PrescriptionsPharmacistsAdultAgedAnxietyAnxiety DisordersClinical CompetenceDepressionFemaleGeneral PracticeHumansMaleMental DisordersMiddle AgedPilot ProjectsPrimary Health CareAnxiety disordersDepressive disordersIndependent prescriberPharmacistPrimary careResearch evaluationScotland

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.